MRI continues to advance diagnostic precision, with gadolinium-based contrast agents (GBCAs) playing a critical role in enhancing image clarity. Gadopiclenol, a new high-relaxivity GBCA, offers improved diagnostic outcomes with potentially lower doses, making it essential for clinicians to understand its application in practice. There is a need to share experiences and insights on converting to Gadopiclenol for body, cardiac, and neuroradiology imaging to optimize its use. Additionally, understanding the safety and tolerability of this new agent is vital for its successful adoption. These presentations aim to equip healthcare professionals with the knowledge needed to improve patient care using this innovative contrast agent.
- Understand the clinical benefits of Gadopiclenol
- Explore practical applications of Gadopiclenol in body, cardiac, and neuroradiology MRI
- Evaluate the safety and tolerability of Gadopiclenol
- Identify strategies to successfully integrate Gadopiclenol into clinical MRI protocols while maintaining patient safety and optimizing diagnostic outcomes.
The content of this CME webinar is intended for healthcare professionals including radiologists, other physicians, radiologic and imaging nurses, facility managers, researchers, and others.
This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of Northwest Imaging Forums. NWIF is accredited by the ACCME to provide CME for physicians. NWIF designates this educational activity for 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity for which they attended.
Nurses may claim credit for activities approved for AMA PRA Category 1 Credits™ in most states, for up to 50% of the nursing requirement for recertification. This course is designated for 1.0 AMA PRA Category 1 Credits™.
Release Date: 03/23/2026 | Expires: 03/23/2027
Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, Northwest Imaging Forums, Inc. (NWIF) ensures balance, independence, objectivity, and scientific rigor in all its educational activities. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planners are required to disclose all financial relationships with ineligible companies within the last 24 months. All relevant financial relationships have been mitigated by NWIF to ensure the integrity of the CME activity. The planner has nothing to disclose.
Rajan T. Gupta, MD
Vice Chair, Clinical Affairs, Professor of Radiology, Professor in Urology, Director of Imaging
Duke Cancer Institute Center for Prostate & Urologic Cancers
Durham, NC
Neil M. Rofsky, MD, MHA, FACR
The Dr. Charles M. and Marilyn Newman Professor
System Chair, Department of Diagnostic, Molecular and Interventional Radiology
Senior Associate Dean of Wellness and Coaching, Icahn School of Medicine
Mount Sinai Health Systems
New York, NY
Robert W. W. Biederman, MD, FACC, FAHA, FSCMR, FASA
Professor of Medicine, West Virginia University, Morgantown, WV
Professor of Bioengineering, Carnegie Mellon University, Pittsburgh, PA
Professor of Medicine, Medical University of South Carolina/Roper-Saint Francis Hospital, Charleston, SC
Emanuel Kanal, MD, FACR, FISMRM, MRMD/SE, AANG
Chief, Division of Emergency Radiology
Director, Magnetic Resonance Services
Professor of Radiology and Neuroradiology
University of Pittsburgh Medical Center
University of Pittsburgh School of Medicine
Pittsburgh, PA
Professor of Medicine, West Virginia University, Morgantown, WV;
Professor of Bioengineering, Carnegie Mellon University, Pittsburgh, PA;
Professor of Medicine, Medical University of South Carolina/Roper-Saint Francis Hospital, Charleston, SC
Disclosures:
- Kiniksa: Honorarium/Speaker
- Amgen: Honorarium/Speaker
- Bristol Meyers Squibb: Honorarium/Speaker
- Janssen: Honorarium/Speaker
- Lantheus: Honorarium/Speaker
The Dr. Charles M. and Marilyn Newman Professor; System Chair, Department of Diagnostic, Molecular and Interventional Radiology;
Senior Associate Dean of Wellness and Coaching, Icahn School of Medicine, Mount Sinai Health Systems, New York, NY
Disclosures:
- No financial relationship within the past 24 months
Chief, Division of Emergency Radiology; Director, Magnetic Resonance Services;
Professor of Radiology and Neuroradiology, University of Pittsburgh Medical Center, Pittsburgh, PA
Disclosures:
- No financial relationship within the past 24 months
Vice Chair, Clinical Affairs; Professor of Radiology; Professor in Urology;
Director of Imaging, Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC
Disclosures:
- Bard: Consultant
- Bayer Pharma AG: Consultant & Speakers Bureau
- Bracco Diagnostics: Consultant
- Philips: Consultant
- Quibim: Consultant
- RoClub: Consultant
Video Only – Click Here
If you wish to receive credit, please click on the
Take this Course button above.
Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.
